Tag: Biotechnology

MaaT Pharma
Europe

MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer

March 21, 2024 01:00 PM Eastern Daylight Time LYON, France–(BUSINESS WIRE)–Regulatory News: Jonathan’s expertise and extensive experience will be instrumental in securing strategic partnerships and maximizing the potential of our pipeline.Post this MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival for patients with cancer, today announced the appointment of … Continue reading MaaT Pharma Strengthens Executive Team Appointing Jonathan Chriqui as Chief Business Officer

Impact Newswire
Bienaimé
United States

Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin

March 25, 2024 04:00 AM Eastern Daylight Time This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240325371093/en/ PARIS–(BUSINESS WIRE)–Owkin, a TechBio that combines the best of human and artificial intelligence to find the right treatment for every patient, is very pleased to announce the appointment of Jean-Jacques Bienaimé as Chairman to its Board of Directors. “We are thrilled to have Jean Jacques Bienaimé join … Continue reading Jean-Jacques Bienaimé Appointed Chairman of the Board at Owkin

Impact Newswire
AffyImmune Therapeutics
United States

AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC

March 19, 2024 08:00 AM Eastern Daylight Time NATICK, Mass.–(BUSINESS WIRE)–AffyImmune Therapeutics, Inc., a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, affinity-tuned CAR T cell therapies, announced today the appointment of Matt Britz to Chief Executive Officer and Pete Gelinas as Senior Vice President of Chemistry, Manufacturing, and Controls. “Matt has been an instrumental part of AffyImmune’s growth in the past two years”Post this … Continue reading AffyImmune Therapeutics Appoints Matt Britz as Chief Executive Officer and Pete Gelinas as SVP of CMC

Impact Newswire
Portal Biotechnologies
United States

Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC

March 19, 2024 06:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, with participation from Conscience VC and 10x Capital. “Through their platform focused business model, we hope to see broad impact across applications that could ultimately benefit many patients.”Post this Portal is implementing a simplified approach to … Continue reading Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC

Impact Newswire
Cellino
United States

Cellino Announces Ed Tekeian as Senior Vice President of Engineering

–Tekeian will oversee the development of Cellino’s scalable manufacturing platform for personalized regenerative medicines. March 18, 2024 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cellino Biotech, Inc., a preclinical biotechnology company building an autonomous biomanufacturing platform for personalized regenerative medicine, today announced the expansion of its executive leadership team with the addition of Ed Tekeian as Senior Vice President of Engineering. As an experienced engineering … Continue reading Cellino Announces Ed Tekeian as Senior Vice President of Engineering

Impact Newswire
Global, United States

Comtech Appoints John Ratigan as Interim Chief Executive Officer

Mark Quinlan Named Chair of the Board March 13, 2024 09:00 AM Eastern Daylight Time MELVILLE, N.Y.–(BUSINESS WIRE)–Comtech (NASDAQ: CMTL) (the “Company”) today announced that its Board of Directors has appointed John Ratigan, Chief Corporate Development Officer (“CCDO”), as interim Chief Executive Officer, effective immediately. Mr. Ratigan succeeds Ken Peterman, who has been terminated as President and CEO and will cease to serve on the … Continue reading Comtech Appoints John Ratigan as Interim Chief Executive Officer

Impact Newswire
ELICIT PLANT
Global, United States

Elicit Plant Announces the Appointment of Slavica Djonovic, Ph.D, as Chief Scientific Officer (CSO)

March 07, 2024 01:28 PM Eastern Standard Time MOULINS-SUR-TARDOIRE, France–(BUSINESS WIRE)–Elicit Plant, a pioneering and rapidly expanding agri-biotech company, announces the appointment of the renowned scientist and a leader in the ag-tech industry, Slavica Djonovic, Ph.D. as Chief Scientific Officer (CSO). An author of more than 20 patent family applications in the space of biomolecular and biological innovations for plant stress, her appointment reflects Elicit … Continue reading Elicit Plant Announces the Appointment of Slavica Djonovic, Ph.D, as Chief Scientific Officer (CSO)

Impact Newswire
Europe, Global

Cultivated Biosciences Secures $5 Million in Seed Funding to Bring Alternative Dairy Products Closer to Dairy

ZURICH, Switzerland–(BUSINESS WIRE)–Cultivated Biosciences, a pioneering Swiss biotech food startup, is thrilled to announce the successful closing of its $5 million seed funding round. This significant financial injection will accelerate both the development of their yeast cream in collaboration with the food industry and preparation for the US market launch in 2025. The dairy-free sector has experienced considerable growth and innovation recently. Still, the products … Continue reading Cultivated Biosciences Secures $5 Million in Seed Funding to Bring Alternative Dairy Products Closer to Dairy

Impact Newswire